TURKISH JOURNAL OF MEDICAL SCIENCES, vol.50, no.1, pp.31-36, 2020 (SCI-Expanded)
Article / Article
TURKISH JOURNAL OF MEDICAL SCIENCES
Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, TR DİZİN (ULAKBİM)
Anti-interleukin-6, tocilizumab, Takayasu's arteritis, GIANT-CELL ARTERITIS, DISEASE-ACTIVITY, CASE SERIES, EFFICACY, RESISTANT, SAFETY
Hacettepe University Affiliated:
Background/aim: Tumour necrosis factor inhibitors and anti-interleukin-6 (anti-IL-6) therapies are increasingly being used in Takayasu's arteritis (TA) patients who are unresponsive to corticosteroids +/- conventional immunosuppressive agents. The aim of this study is to assess the efficacy and safety of anti-IL-6 (tocilizumab) therapy in refractory TA patients in real life.